We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

19 hedge funds and large institutions have $32.3M invested in Alpine Immune Sciences Inc in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $34.4M → $32.3M (-$2.04M)

10% less funds holding

Funds holding: 21 → 19 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$48.2K
2
Deutsche Bank
Deutsche Bank
Germany
+$3.32K

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$520K
2
DM
Deerfield Management
New York
-$492K
3
AWCI
Alpine Woods Capital Investors
New York
-$13.8K
4
Bank of America
Bank of America
North Carolina
-$1K
5
HP
Hikari Power
Japan
-$935
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$14.1M – – –
FM
2
Frazier Management
Washington
$9.87M – – –
BI
3
BVF Inc
California
$4.37M – – –
DM
4
Deerfield Management
New York
$956K -$492K -157,934 -39%
Vanguard Group
5
Vanguard Group
Pennsylvania
$718K – – –
HP
6
Hikari Power
Japan
$712K -$935 -300 -0.2%
TM
7
Tiger Management
New York
$529K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$491K +$48.2K +15,449 +14%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$177K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$143K – – –
BlackRock
11
BlackRock
New York
$92K -$374 -120 -0.5%
AWCI
12
Alpine Woods Capital Investors
New York
$41K -$13.8K -4,420 -29%
Northern Trust
13
Northern Trust
Illinois
$39K -$224 -72 -0.7%
DS
14
DRW Securities
Illinois
$38K – – –
LRIA
15
Leonard Rickey Investment Advisors
Washington
$38K – – –
IC
16
Ikarian Capital
Texas
$18K +$14.8K +4,739 New
Deutsche Bank
17
Deutsche Bank
Germany
$4K +$3.32K +1,065 New
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$1K -$330 -106 -30%
Victory Capital Management
19
Victory Capital Management
Texas
– -$520K -132,603 Closed
Bank of America
20
Bank of America
North Carolina
– -$1K -366 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$12 -4 -16%

ALPN Hedge Fund Activity: Q4 2019 in Review

19 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2019, worth a combined $32.3M — down 5.9% from $34.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ALPN and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $48.2K. The largest seller was Victory Capital Management, exiting entirely with an estimated $520K sold.

  • 19 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2019, down from 21 in Q3 2019.
  • Funds reported $32.3M of Alpine Immune Sciences Inc stock for Q4 2019, down 5.9% quarter-over-quarter.
  • 2 funds opened new Alpine Immune Sciences Inc positions in Q4 2019 and 4 closed out, a net change of -2 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q4 2019 was Renaissance Technologies, an estimated $48.2K added.
  • The largest Alpine Immune Sciences Inc seller in Q4 2019 was Victory Capital Management, an estimated $520K sold.

Based on aggregated 13F filings for Q4 2019.